Paul O’Nion joins RSSL

To head the expansion of gas chromatography and mass spectrometry services

Paul O'Nion has joined the pharmaceutical department at RSSL to head the gas chromatography team, and to oversee expansion of RSSL's gas chromatography – mass spectrometry (GC-MS) services. GC-MS technology is used in the investigation of trace levels of contamination, and other impurities in pharmaceutical products.

O’Nion joins RSSL from AWE Aldermaston. He is a chartered chemist and an assessor for the analytical chemistry NVQ from the Royal Society of Chemistry. He is a graduate of Birmingham University.

You may also like

Manufacturing

Biopharma boom brings benefits to CROs

The analytical outsourcing sector is well placed to benefit from the continuing rise in biopharmaceutical manufacturing
Manufacturing

Extractables and leachables testing — a risk based approach

Peter Bennett, a Technical Specialist has written the latest white paper from RSSL providing a risk based approach for extractables and leachables testing
Manufacturing

Key to outsourcing method development and validation

Linda Forsyth and Steve Alley, RSSL, present a white paper on developing a method of outsourcing and the validating activities required
Manufacturing

Good manufacturing practice for medical devices

An interactive good manufacturing practice training course, which covers the required standards and regulatory framework to market a medical device
Manufacturing

Impurity isolation and sample purification

RSSL is now offering a service in preparative HPLC to help customers isolate impurities and also purify reference standards
Manufacturing

RSSL safeguards staff with SoloProtect

<p>Reading Scientific Services (RSSL) has purchased SoloProtect from Connexion2 of Sheffield, which safeguards laboratory workers who are operating alone at night or at weekends.</p>
Manufacturing

WuXi AppTec peptide facility receives PMDA approval

The company's Changzhou oligonucleotide API manufacturing site was approved by Japan's Pharmaceuticals and Medical Devices Agency
Subscribe now